Clinical Trials Logo

Clinical Trial Summary

This was a prospective randomized controlled study comparing the efficacy of micro-focused ultrasound when used in conjunction with 1550-nm erbium-doped fractionated laser versus 1550-nm erbium-doped fractionated laser alone for treatment of striae distensae(stretch marks). Each side of thigh (or abdomen) was randomized to receive 1550nm-fractionated laser treatment every 2 weeks for a total of 4 treatments on one side and the contralateral side received micro-focused ultrasound treatment and 1550nm-fractionated laser alternatively every 2 weeks for a total of 4 treatments with site-match control area of baseline striae on each side. The primary outcome measure by two dermatologists blindly compared the two areas of striae distensae on each side from live subjects using a questionnaire and quartile rating scale on the final follow-up visit. This study was a pilot study designed to determine the feasibility of these procedures.


Clinical Trial Description

The secondary outcomes were qualitative measurements of the mean striae width in the treatment area before(week0) and after treatment(week10) and subject satisfaction was determined by a satisfaction questionnaire. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01186848
Study type Interventional
Source Northwestern University
Contact
Status Completed
Phase N/A
Start date August 2010
Completion date June 2011

See also
  Status Clinical Trial Phase
Completed NCT05097157 - Study To Assess A Radiofrequency Microneedling Device For Dermatologic Conditions N/A
Completed NCT02601105 - Topical Centella Asiatica and the Cosmetic Appearance of Stretch Marks N/A
Recruiting NCT05847530 - Pilot Evaluation of the Cynosure Potenza™ System for Treatment of Cosmetic Dermatologic Skin Conditions N/A
Completed NCT01027793 - Trial Comparing Treatment of Tretinoin or Superficial Dermabrasion for Stretch Marks Phase 4
Completed NCT03931525 - Effect of Radiofrecuency on Stretch Marks N/A
Terminated NCT00129415 - Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions Phase 1/Phase 2